Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6131-6140 of 13615

Page
per page
  1. OSU-T315
    C9112 OSU-T315
    Summary: An ILK inhibitor and signaling probe for in vitro AKT pathway research, for research use only.
  2. Atglistatin
    B3021 Atglistatin
     1 Citation
    Target: ATGL
    Summary: ATGL inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.15 mg/mL
  3. Daunorubicin HCl
    B2285 Daunorubicin HCl
    Summary: DNA topoisomerase II inhibitor
      ≥28.2 mg/mL
  4. Butaprost
    B7931 Butaprost
    Summary: Structural analog of PGE2, a selective agonist for the EP2 receptor subtype
      Soluble in DMSO
  5. Erythritol
    B1747 Erythritol
    Summary: Sugar alcohol
      insoluble in EtOH; ≥115.6 mg/mL
  6. Ethacridine lactate monohydrate
    B1749 Ethacridine lactate monohydrate
     1 Citation
    Summary: Antiseptic agent
      ≥17.05 mg/mL
  7. 4-Bromo-3-hydroxybenzoic acid
    C7021 4-Bromo-3-hydroxybenzoic acid
    Summary: A metabolic derivative that inhibits histidine decarboxylase (HDC) and aromatic amino acid decarboxylase
      ≥21.3 mg/mL
  8. Cy5.5 maleimide (non-sulfonated)
    A8140 Cy5.5 maleimide (non-sulfonated)
     1 Citation
    Summary: Cy5.5 maleimide (non-sulfonated), labels thiols.
      ≥74.1 mg/mL
  9. Metergoline
    B6365 Metergoline
    Summary: 5-HT1/5-HT2 antagonist
      Soluble in DMSO
  10. AH 11110 hydrochloride
    B6541 AH 11110 hydrochloride
    Summary: α1B-AR ligand,subtype-selective
      Soluble to 25 mM in H2O

Items 6131-6140 of 13615

Page
per page